US20150094237A1 - Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants - Google Patents

Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants Download PDF

Info

Publication number
US20150094237A1
US20150094237A1 US14/565,323 US201414565323A US2015094237A1 US 20150094237 A1 US20150094237 A1 US 20150094237A1 US 201414565323 A US201414565323 A US 201414565323A US 2015094237 A1 US2015094237 A1 US 2015094237A1
Authority
US
United States
Prior art keywords
protein
carbohydrate
binding
carbohydrates
microarray
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/565,323
Inventor
Pi-Hui Liang
Chi-Huey Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Academia Sinica
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academia Sinica filed Critical Academia Sinica
Priority to US14/565,323 priority Critical patent/US20150094237A1/en
Assigned to ACADEMIA SINICA reassignment ACADEMIA SINICA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WONG, CHI-HUEY, LIANG, PI-HUI
Publication of US20150094237A1 publication Critical patent/US20150094237A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/12Libraries containing saccharides or polysaccharides, or derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Definitions

  • This disclosure related to sensitive, high throughput, glycan microarray systmes, methods and devices for examining carbohydrate-protein interactions on surface and in solution. More particularly, the glycan microarray is a platform for using very small amounts of materials.
  • the glycan microarray supports mulivalent interactions and may be used to determine the surface dissociation constant (K D, surf ).
  • Carbohydrates can be envisioned as the K'nexTM toys of life. They are building blocks with multiple points of attachment, which can form highly brached and sterochemically-rich structures. They are difficult to study because the connecting points are not as sturdy as the K'nex. In fact, the binding force is very weak compared to the binding force of an antigen or antibody. The affinities, i.e., the force of attraction between molecules, of the latter can be 10 3 -10 9 greater. Therefore, it is very difficult to synthesize a sufficient quantity of a carbohydrate for lab analysis. Traditionally it may take a day or more to measure a single carbohydrate-protein interaction using compounds in microgram to milligram amounts.
  • Carbohydrates present as free oligosaccharides or as glycoconjugates, play an important role in many biological events, particularly those involving cell surfaces. Specific interactions between carbohydrates and proteins are often essential in viral and bacterial infection, the immune response, differentiation and development, and the progression of tumor cell metastasis. Therefore an understanding of carbohydrate-protein interactions at the molecular level would lead to a better insight into the biological process of living systems and assist the development of therapeutic and diagnostic strategies.
  • the glycan microarray or “sugar-chip” disclosed herein is a platform for the investigation and manipulation of carbohydrate-protein interactions. Assessing carbohydrate affinities is typically difficult due to weak affinities and limited sources of structurally complex glycans. Disclosed herein is a sensitive glycan microarry technology for the simultaneous determination of a wide variety of parameters in a single experiment using small amounts of materials. In some aspects this microarray is also high throughput.
  • a dense carbohydrate microarray for quantitative protein measurements may comprise: a solid substrate configured to provide a supporting substance; and a reactive layer fabricated on the solid substrate, the reactive layer comprising at least one reactive group of small molecules; wherein the at least one reactive group of small molecules is configured to bind with at least one protein, wherein the at least one protein are immobilized on the solid substrate via the reactive layer; wherein the carbohydrate microarray is configured to perform a quantitative measurement of binding ability with the at least one protein; wherein at least three different concentrations of the at least one protein are provided in one chip; wherein the binding affinity between the small molecules and the at least one protein can be measured; wherein the small molecules comprise at least one of carbohydrates and glycolipids; wherein the small molecules are disposed relative to each other to allow the at least one protein to multivalently bond with the small molecules.
  • a kit may comprise: a high throughput carbohydrate microarray comprising carbohydrate spots on a solid substrate, each of the carbohydrate spots having a reactive group of at least one of carbohydrates and glycolipids, wherein the carbohydrates spots are configured to react with and bind to at least one protein; wherein the reactive groups are disposed relative to each other to allow the at least one protein to multivalently bond with the reactive groups; a microarray reader; and instructions for use.
  • a method for identifying a protein bound to a microarray of attomol quantity carbohydrates may comprise: forming a glycan microarray of spotted sugars in concentrations each of about 10 ⁇ 18 mole; adding a labeled protein to the microarray; incubating the micrarray; and, using an array reader to identify labeled proteins on the glycan microarray.
  • FIG. 1 shows an implementation of glycan microarray fabrication and detection.
  • the N-hydroxysuccinimide (NHS) activated glass slide was printed with Man1 at a range of concentrations between 100 mM and 0.5 fM. Fluorescent images were then probed with FITC labeled Con A. The detection limit was determined to be at 1 nM printing concentration and atto-mol quantities of sugars per spot. Arrow refers to the printing concentration. The white bar (bottom right) equals 0.5 mm length. Limit of detection is signal to noise greater than 10 (s/n ⁇ 10). At this value, the sugar concentration (attomol) of samples are sufficient to meet the defined detection limits. (1 attomol is 10 ⁇ 18 mol of a molecule.)
  • FIG. 2 shows an implementation of (a) Mono-mannose cadaverine was printed with concentrations of 100 (first left column), 80, 60, 40, 30, 20, 10, 8, 6, 4, 2, 1, 0.8, 0.6, 0.4, and 0.1 ⁇ M (first right column). The images were obtained from slides incubated with different concentrations of FITC labeled Con A (from 800 nM to 25 nM as indicated above each square). (b) Binding curves for Man 1 printed at different concentrations are shown. The curves were obtained using FITC labeled Con A. The K D, surf values were obtained by fitting the curves in panel A to eq 1.
  • FIG. 3 shows implementations of (a) structures of Man4, Man8, Man9; and (b) the binding curves were obtained from the function of lectins or antibody concentration and fluorescence intensity determined from array images.
  • K D surf values obtained by fitting the curves to eq 1.
  • the error bars indicated in the figures show the average percentage error for all data points reported in the figures.
  • FIG. 4 shows implementations of (a) competition experiment between solution and surface Man8 for FITC-Man8. At different concentrations of the competitor, binding curves were obtained from the bound Con A concentrations and fluorescence intensities; and (b) the K D values were determined from a re-plot of the K D app versus free Man8 concentrations according to eq 2.
  • FIG. 5 shows binding curves obtained from implementations of the bound Man 1 -Con A concentrations and fluorescence intensities. Different curves mean different concentrations of competitor (( ⁇ -methyl)-mannose in the solution.
  • FIG. 6 shows implementations of (a) structure of FITC cadaverine.
  • (b) FITC cadaverine was printed with different concentrationsfrom 100 mM (first left column), 50 mM, 10 mM, 5 mM, 1 mM, 500 ⁇ M, 100 ⁇ M, 50 ⁇ M, 10 ⁇ M, 5 ⁇ M, 1 ⁇ M, 500 nM, 100 nM, 50 nM, 10 nM, 5 nM, 1 nM, 500 pM, 100 pM, 50 pM, 10 pM, 5 pM, 1 pM, 500 fM, 100 fM, 50 fM, 10 fM, 5 fM, 1 fM, 0.5 fM (first right column).
  • FIG. 7 illustrates implementations of sugar chips at different concentrations. Each dark group of four circles represents a protein. The large protein is shown interacting with the light array members. In FIG. 7 a the array members are physically closer together; a protein may therefore interact multivalently as opposed to the situation in FIG. 7 b wherein the physical gap between array members makes it difficult for a protein to interact with multiple array members at the same time.
  • FIG. 8 is a diagrammatic overview of implementations of a sensitive glycan microarray.
  • the sugar fixed to the surface of the substrate interacts with different concentrations of lectin (shown here with a fluorescence attached).
  • concentrations of lectin shown here with a fluorescence attached.
  • each concentration of inhibitor will generate an isotherm (right bottom chart). Based on the isotherms, the solution KD or Ki for the inhibitors may be obtained.
  • FIG. 9 shows a table providing data on the functions of different printing concentration, and the corresponding fluorescence intensities, and the dissociate constants on surface.
  • FIG. 10 shows a table providing data on competitors and solution Ki values for the interaction with Con A.
  • FIG. 11 shows implementations of quantitative analysis of protein-carbohydrate interactions to obtain surface and solution dissociation constants from glycan arrays.
  • Carbohydrates with reactive groups are immobilized on the array surface.
  • the device (one chip) contains 2 to 50 subarray (*), each subarray contains several carbohydrates.
  • the device When the device are immobilized with one protein (carbohydrate binding protein) with several (at least 3) concentrations, it will generate an isotherm where the apparent dissociation constant (K D, surf ) can be obtained (left isotherm).
  • K D, surf apparent dissociation constant
  • surface-based carbohydrate arrays is used to identify lectin recognition.
  • the presentation of carbohydrates in a microarray provide a system and method to monitor multiple binding events and/or the effects of multivalency.
  • carbohydrate-proetein interactions on cell surface and in solution can be quantitatively measured by glycan microarray.
  • a glycan microarray with attomol-limits of detection (1 attomol is 10 ⁇ 18 mol of a molecule) is diclosed.
  • attomol-limits of detection (1 attomol is 10 ⁇ 18 mol of a molecule) is diclosed.
  • about one milligram of a carbohydrate may be used for a large number of tests.
  • a milligram of carbohydrate may be used as many as 10 12 times.
  • very slight amounts of antibodies in a subject's blood stream, which can not be detected, by any other known method may be detected.
  • a method for the determination of sugar density using fluorescein isothiocyanate cadaverine to discover, confirm and/or solve the distance of two binding sites within one protein.
  • a method to mimic cell surface carbohydrate-protein interactions of at least one of binding mode and strength of carbohydrate-protein interaction is provided.
  • a glycans array to mimic cell surface carbohydrate-protein interactions of at least one of binding mode and strength of carbohydrate-protein interaction which uses a very small amount of carbohydrate.
  • a method is disclosed to characterize sugar binding specificities of proteins.
  • a method for high thorughput identification of inhibitors of carbohydrate-binding proteins.
  • the apparent binding mode and strength of carbohydrate-protein interaction on cell surfaces are disclosed to be mimicked and can be quantitatively analyzed by glycan array in a rapid manner using only a very small amount of carbohydrate.
  • kits of parts can be envisioned by the person skilled in the art, the kits of parts to perform at least one of the methods herein disclosed, the kit of parts comprising one or more microarray devices, a solid substrate configured to provide a supporting substance; and a reactive layer fabricated on the solid substrate, the reactive layer compirising at least one reactive group of small molecules, according to implementations disclosed herein.
  • the kits possibly include devices for reading, operating, interpreting, or processing data produced by the one or more microarrays, as well as instructions for use of the kit and its consituent parts.
  • a kit may include a microarray reader for analyzing a microarray after a reaction.
  • Arraying and detection limit A strategy for covalently attaching a defined glycan to a glass slide was based on the standard microarray robotic printing technology using N-hydroxysuccinimide (NHS) activated glass surface, to which glycans containing an amine linked to the anomeric position were covalently attached. Prior to producing the slides, the challenges of printing concentrations were examined. Because carbohydrates do not fluoresce and modified carbohydrates bearing fluorescent groups might interact differently with the protein, fluorescein isothiocyanate (FITC) cadaverine was used as a model.
  • NHS N-hydroxysuccinimide
  • FITC cadaverine was printed in concentrations ranging from 100 mM to 1 fM and the slide was scanned before and after washing.
  • the surface coverage of FITC was measured in a fluorescence wash-off experiment and the density of maximum loading was found to be 10 14 molecules/cm 2 a similar value to most peptides or sugars attached to SPR biosensor surface. More importantly, at concentrations below 100 ⁇ M, the fraction of surface covered by each molecule varied in proportion to its concentration, while over 500 ⁇ M, the surface seemed to be saturated ( FIGS. 6 a - 6 d ). Next, mono-mannose derivative bearing primary amine (Man1) were printed on the glass slide in concentrations ranging from 100 mM to 0.5 fM ( FIG.
  • FITC labeled Con A was incubated with different printing concentrations of Man1 on the surface, after washing the slide was scanned to get the fluorescence intensities.
  • a binding curve based on printing concentrations and fluorescence intensities was created, and the binding curve reached saturation (in the case of FITC-Con A and Man1, the curve became saturated at 10 ⁇ M printing conc.), which was independent of surface density (surface saturated when printing concentration was over 100 ⁇ M).
  • This saturated curve is an indication of multivalent interaction between protein and printed carbohydrates.
  • the signal intensity in an array depends on the surfrace density of the immobilized carbohydrate, it is essential to normalize carbohydrate concentrations prior to printing.
  • FIG. 2 a depicts photgraphs of glass slides printed at 16 different concentrations with 16 ⁇ 16 pattern of Man1 from 100 ⁇ M (first left column) to 0.1 ⁇ M (first right column). The arrays were probed with ten concentrationsof protein-FITC labeled Con A, ranging from 800 nM to 25 nM. Con A concentrations were plotted against median fluorescence intensities of replicate spots to give a set of curves ( FIG. 2 b ). The curves were analyzed as Langmuir isotherms, assuming that the sytem reached equilibrium during incubation,
  • Con A is capable of forming two attachment points to the surface and the distance between these points is approximately 65 ⁇ .
  • the distance between mannose residues on the surface is close enough such that on average, an adsorbed Con A can bind to two mannose residues.
  • the printing concentration is below 10 mM, the average distance (spatial separation) between immobilized mannose residues is too far for a multivalent interaction with Con A.
  • FIG. 7 provides a diagrammatic overview of the impact of concentration on multivalent binding.
  • Each black group of four circles represent a protein.
  • the protein is respresentative of Con A which has 4 binding sites (each site is separated by a distance of about 6.5 nm).
  • the light grey dots attached to the substrate are representative of sugar on the surface.
  • FIG. 7 a When printing of the sugars is at low concentration the distance between any 2 sugars is represented in FIG. 7 a .
  • FIG. 7 a the distance between 2 binding sites is too far for the protein with multiple binding sites to interact with more than one sugar.
  • FIG. 7 b represents the sugars printed at a higher concentration, in this case sugars have spatial separation which is close enough for the protein to interact with 2 sugars.
  • the KD, surf values indicated that for a printing con ⁇ 1 ⁇ M, the K D, surf value increased and there was less tight binding at this low concentration the average distance between 2 sugars (glycans) is about 10 nm.
  • the mannose binding lectings Con A, Lens culinaris agglutinin (LCA), Pisum sativum agglutinin (PSA), and the human monoclonal antibody-2G12 were each incubated with sugar arrays in different concentrations.
  • the garden pea lectin PSA is thought to have the same binding specificity to LCA, but in this experiment it was found that the binding trend of PSA to these oligosaccharides was similar to Con A, albeit weaker (up to two orders of magnitude).
  • the human monoclonal antibody 2G12 against the mannose epitope of gp120 on HIV was reported to be in favor of the Mana1-2 Man structure. From this study, Man1 has no interaction and Man4 displayed the strongest interaction with K D of 140 nM. These values were consistent with previous measurements from the microtiter plate assay.
  • the threshold varies from one carbohydrate to another and is based on how well the carbohydrate behaves in the assay. Even when closely related glycans are studied under ideal conditions, they vary with respect to the surface density of active carbohydrates. Since the intensity of a spot depends both on K D, surf (which results from binding affinity), and F max (which results from surface active carbohydrate density and protein binding), the information obtained by probing an array with a single concentration of analytes may not be accurate. This present disclosures show that quantitative measurements can be carried out to accurately study the nature of carbohydrate-protein interaction on a cell surface.
  • the solution equilibrium dissociation constant (K D ) for carbohydrate-lectin interactions can be determined using microarrays in a competitive assay. The analysis allows for the direct comparison between microarry affinities measurements to those obtained from solution-based affinity measurements.
  • carbohydrates in solution compete with immobilized carbohydrate ligands for the binding sites on the lectin, establishing a coupled equilibrium between the binding of proetin to the immobilized species and to the species present in the solution.
  • the unbound protein concentration [P] can be obtained via Langmuir isotherms (eq 1). Once the concentration of P has been measured, it is possible to determine the KD using eq 2, which is derived from the multivalent Scatchard formula (see the Experimental Section for the derivation of eq 2)
  • a competition binding experiment was performed by treating Con A to various oligomannoses, followed by incubation with corresponding oligomannoses surface. Binding curves, representing different concentrations of competitors were obtained as the function of FITC-Con A concentrations and fluorescence intensities from the Man8 surface ( FIG. 4 a ). The data was analyzed according to eq 2, to afford apparent K D values, which were then replotted against competitor concentration to afford the solution K D values ( FIG. 4 b ). Using this analysis, the K D values for Man1, Man4, Man8, Man9 for Con A were found to be 250 ⁇ M, 55 ⁇ M, 0.42 ⁇ M, and 0.13 ⁇ M, respectively.
  • the glycan array system described here offers several features that make it attractive as a tool for glycomics: it requries small quantities of materials (10 ⁇ 18 mole) for high-throughput analysis, and can be used for quantitative analysis of carbohydrate-protein interaction on surface and in solution.
  • the disclosed system is considered to be a good mimic of cell-surface arrays of carbohydrates in which the dissocation constants of multivalent interactionscan be determined for comparison with the monovalent, solution dissociation constants determined through the competition analysis.
  • Microarray Fabrication Microarrays were printed (Genomic Solutions, Gene Machine) by robotic pin (SMP2B, TeleChem International Inc.) deposition of ⁇ 0.6 nL of various concentrations of amine-containing glycans in print buffer (300 mM phosphate, pH 8.5 containing 0.005% Tween-20) from a 384 well plate onto slides.
  • print buffer 300 mM phosphate, pH 8.5 containing 0.005% Tween-20
  • the slides surface was divided by drawing with permanent marker to avoid contamination for later protein incubation;
  • the slide for FIG. 2 was printed with Man1 with concentrations of 100 (first left column), 80, 60, 40, 30, 20, 10, 8, 6, 4, 2, 1, 0.8, 0.6, 0.4, and 0.1 mM (first right column, 16 different conc.) from left to right with 16 replicates vertically placed in each grid and totally 24 replicates (8 ⁇ 3 pattern) sub-arrays in one slide;
  • the slides for K D, surf and K D determination the slides were printed of Man1, Man4, Man8, Man9 with concentration of 100 ⁇ M from right to left 16 replicates vertically placed in each grid and totally 24 sub-arrays replicates in one slide.
  • FITC cadaverine ( FIG. 6 a ) with concentration from 100 mM to 1 fM were printed onto the slide in 16 replicates and read at A488 by array scanner (Applied Precision). After 12 hr reaction at dark, the slide was washed with PBST (0.05% Tween 20) buffer. The slide was dried, and then read again at A488 by array reader ( FIG. 6 b ). The average intensity from each concentration was plotted ( FIG. 6 c ). The curve showed that at concentrations below 100 ⁇ M, the fraction of surface covered by each molecule varied in proportion to its concentration ( FIG. 6 d ). Over 500 ⁇ M, the surface seems to be saturated ( FIG. 6 c ). The number of FITC that remain bound to the surface (Np) is calculated by eq 3.
  • Np CVN A ⁇ Qpost Qpre ( 3 )
  • N A is Avogadro's Number.
  • Each spot in the array is around 0.1 mm diameter.
  • the ratio from pre-quench (Qpre) to post-quench (Qpost) is 0.23 (obtained from the array scanner measurement before and after washing). Based on equation 3, the surface density is between 1.8 ⁇ 10 14 molecules/cm 2 and 8.8 ⁇ 10 14 molecules/cm 2 . When the printing concentration at 1 mM, the ratio of Qpost/Qpre is 0.1, the density is 0.77 ⁇ 10 12 molecules/cm 2 . If the surface was assumed to be of a homogenous distribution, the average space between each molecule is 115 ⁇ 10 ⁇ 8 m (115 ⁇ ).
  • FITC-labeled Con A (4 mg/ml), FITC-labeled PSA (2 mg/ml), FITC-labeled LCA (2 mg/ml), were diluted in PBS-BSA buffer 50 mM, pH 6.5; 1 mM CaCl 2 , 1 mM MnCl, 0.9% NaCl (w/v), 1% BSA (w/v)).
  • Human monoclonal antibody-2G12 was used in PBST buffer with 1% BSA.
  • 10-25 ⁇ L of protein solution was applied to each sub-array using a 24 well bottomless incubation chamber (The Gel Company).
  • Humidifying incubation was performed under foil and using a shaker for 1 h at room temperature.
  • the slide was washed three times with incubation buffer, three times with PBST buffer (0.05% Tween-20), three times with distilled water, and then centrifuged at 200 g for 5 min to ensure complete dryness.
  • the array was then imaged at a resolution of 5 ⁇ mwith a A488 laser using ArrayWorx microarray reader to visualize fluorescence.
  • the method for the interaction of human monoclonal antibody-2G12 with sugars was similar to lectin.
  • 2G12 in PBST buffer with 1% BSA was pre-complex with Cy3 labeled goat anti-human IgG (Jackson ImmunoResearch) and then placed to the slide and incubated for 1 h.
  • the images were read using A595 laser with the array reader.
  • the concentration of unoccupied ligand [L] is the difference between the total amount of ligand [Lo] and the amount of [LP]. Substituting [Lo]-[LP] for [L] in eq 4 gives
  • [LP*] is the concentration of protein/ligand complexes
  • [P] is the concentration of free protein
  • [L] is the concentration of free ligand. Since a multivalent protein (P) may have q binding sites (B), the concentration of free binding sites [B] is equal to q[P]. Likewise, the formation of a binding site/ligand complex [BP*] is equal to q[LP*]. From the eq 7, both numberator and denominator muliply q value. The interaction of one acceptor binding site with ligand can be represented as
  • a value is defined as ratio of free protein and total protein which is then substituted [LP*] value by eq 7 and rearranged to give eq 9.
  • inhibitors (I) in the solution a ligand (L) on the surface and multivalent protein (P) can be represented as
  • the array imaging data is used to measure [P] and K i can be determined by the eq 10.
  • the fraction of inhibition (f) is equal to 1-F/Fmax, the equation from eq 10 can be rearranged to give eq 11.
  • Shown in FIG. 8 is an exemplar of a method and process of a sugar fixed to the surface of an array substrate interacting with different concentrations of lectin (which a fluorescence attached).
  • lectin which a fluorescence attached.
  • each concentration of inhibitor can generate an isotherm (right bottom chart.). Based on the isotherms the solution K D or K i for the inhibitors may be obtained.

Abstract

A method, system and device to identify, study and/or mimic carbohydrate-protein interactions on cell surfaces and in solution measured by a glycan microarray. In some instances the method, system and device uses very small quantities of carbohydrate as low as attomol. In some instances the system, method and device is high-throughput. The small quantity senstivity may allow for close placement of carbohydrate array members wherein due to close proximity multivalent interactions with proteins may be identified.

Description

    RELATED APPLICATIONS
  • This application is a divisional of U.S. patent application Ser. No. 12/422,733, filed Apr. 14, 2009, which claims the benefit and priority to U.S. Provisional Application Ser. No. 61/049,358, filed Apr. 30, 2008, the contents of each of which are herein incorporated by reference as if set forth in their entirety.
  • FIELD OF DISCLOSURE
  • This disclosure related to sensitive, high throughput, glycan microarray systmes, methods and devices for examining carbohydrate-protein interactions on surface and in solution. More particularly, the glycan microarray is a platform for using very small amounts of materials. The glycan microarray supports mulivalent interactions and may be used to determine the surface dissociation constant (KD, surf).
  • BACKGROUND
  • Carbohydrates can be envisioned as the K'nex™ toys of life. They are building blocks with multiple points of attachment, which can form highly brached and sterochemically-rich structures. They are difficult to study because the connecting points are not as sturdy as the K'nex. In fact, the binding force is very weak compared to the binding force of an antigen or antibody. The affinities, i.e., the force of attraction between molecules, of the latter can be 103-109 greater. Therefore, it is very difficult to synthesize a sufficient quantity of a carbohydrate for lab analysis. Traditionally it may take a day or more to measure a single carbohydrate-protein interaction using compounds in microgram to milligram amounts.
  • Carbohydrates, present as free oligosaccharides or as glycoconjugates, play an important role in many biological events, particularly those involving cell surfaces. Specific interactions between carbohydrates and proteins are often essential in viral and bacterial infection, the immune response, differentiation and development, and the progression of tumor cell metastasis. Therefore an understanding of carbohydrate-protein interactions at the molecular level would lead to a better insight into the biological process of living systems and assist the development of therapeutic and diagnostic strategies.
  • Despite the ubiquity and importance of carbohydrates in biology, difficulties in the study of carbohydrate-protein interactions have hindered the development of a mechanistic understading of carbohydrate structure and function. The structural compolexity of carbohydrates is a major obstacle: while the other two classes of biopolymers, nucleic acid and proteins, have a linear arrangement of repeating units, carbohydrate building blocks have multiple points of attachment, leading to highly branched and stereochemically-rich structrures. In addition, binding affinities are weak typicall in the ˜10−3-10−6 M range of dissociation constants, compared with antigen-antibody interactions (10−8-10−12). While techniques such as isothermal titration calorimetry (ITC), affinity capillary electrophoresis, surface plasmon resonance (SPR), and frontal affinity chromatography are all significant advances, they are often limited by the amount of available materials. Hence, the design of sensitive and high throughput technologies for characterizing carbohydrate-protein interactions remain a challenge.
  • However, little attention has been paid to the systematic kinetic and thermodynamic investigation of the interactions using glycan microarrays. Recently, MacBeath et al. reported a quantitative analysis of protein-peptide interactions using a protein microarray; in this work the interadctions of Src homology 2 and the phosphotyrosine binding domain of phosphopeptides were measured, and this study provided a better understanding of the tyrosine phosphorylation network for the epidemal growth factor receptor.
  • The glycan microarray or “sugar-chip” disclosed herein is a platform for the investigation and manipulation of carbohydrate-protein interactions. Assessing carbohydrate affinities is typically difficult due to weak affinities and limited sources of structurally complex glycans. Disclosed herein is a sensitive glycan microarry technology for the simultaneous determination of a wide variety of parameters in a single experiment using small amounts of materials. In some aspects this microarray is also high throughput.
  • In some exemplary implementations, a dense carbohydrate microarray for quantitative protein measurements is disclosed. The microarray may comprise: a solid substrate configured to provide a supporting substance; and a reactive layer fabricated on the solid substrate, the reactive layer comprising at least one reactive group of small molecules; wherein the at least one reactive group of small molecules is configured to bind with at least one protein, wherein the at least one protein are immobilized on the solid substrate via the reactive layer; wherein the carbohydrate microarray is configured to perform a quantitative measurement of binding ability with the at least one protein; wherein at least three different concentrations of the at least one protein are provided in one chip; wherein the binding affinity between the small molecules and the at least one protein can be measured; wherein the small molecules comprise at least one of carbohydrates and glycolipids; wherein the small molecules are disposed relative to each other to allow the at least one protein to multivalently bond with the small molecules.
  • In some exemplary implementations, a kit is disclosed. The kit may comprise: a high throughput carbohydrate microarray comprising carbohydrate spots on a solid substrate, each of the carbohydrate spots having a reactive group of at least one of carbohydrates and glycolipids, wherein the carbohydrates spots are configured to react with and bind to at least one protein; wherein the reactive groups are disposed relative to each other to allow the at least one protein to multivalently bond with the reactive groups; a microarray reader; and instructions for use.
  • In some exemplary implementations, a method for identifying a protein bound to a microarray of attomol quantity carbohydrates is disclosed. The method may comprise: forming a glycan microarray of spotted sugars in concentrations each of about 10−18 mole; adding a labeled protein to the microarray; incubating the micrarray; and, using an array reader to identify labeled proteins on the glycan microarray.
  • DRAWINGS
  • The above-mentioned features and objects of the present disclosure will become more apparatent with reference to the following description taken in conjunction with the accompanying drawings wherein like reference numerals denote like elements and in which:
  • FIG. 1 shows an implementation of glycan microarray fabrication and detection. The N-hydroxysuccinimide (NHS) activated glass slide was printed with Man1 at a range of concentrations between 100 mM and 0.5 fM. Fluorescent images were then probed with FITC labeled Con A. The detection limit was determined to be at 1 nM printing concentration and atto-mol quantities of sugars per spot. Arrow refers to the printing concentration. The white bar (bottom right) equals 0.5 mm length. Limit of detection is signal to noise greater than 10 (s/n≧10). At this value, the sugar concentration (attomol) of samples are sufficient to meet the defined detection limits. (1 attomol is 10−18 mol of a molecule.)
  • FIG. 2 shows an implementation of (a) Mono-mannose cadaverine was printed with concentrations of 100 (first left column), 80, 60, 40, 30, 20, 10, 8, 6, 4, 2, 1, 0.8, 0.6, 0.4, and 0.1 μM (first right column). The images were obtained from slides incubated with different concentrations of FITC labeled Con A (from 800 nM to 25 nM as indicated above each square). (b) Binding curves for Man1 printed at different concentrations are shown. The curves were obtained using FITC labeled Con A. The KD, surf values were obtained by fitting the curves in panel A to eq 1.
  • FIG. 3 shows implementations of (a) structures of Man4, Man8, Man9; and (b) the binding curves were obtained from the function of lectins or antibody concentration and fluorescence intensity determined from array images. KD, surf values obtained by fitting the curves to eq 1. The error bars indicated in the figures show the average percentage error for all data points reported in the figures.
  • FIG. 4 shows implementations of (a) competition experiment between solution and surface Man8 for FITC-Man8. At different concentrations of the competitor, binding curves were obtained from the bound Con A concentrations and fluorescence intensities; and (b) the KD values were determined from a re-plot of the KD app versus free Man8 concentrations according to eq 2.
  • FIG. 5 shows binding curves obtained from implementations of the bound Man1-Con A concentrations and fluorescence intensities. Different curves mean different concentrations of competitor ((α-methyl)-mannose in the solution.
  • FIG. 6 shows implementations of (a) structure of FITC cadaverine. (b) FITC cadaverine was printed with different concentrationsfrom 100 mM (first left column), 50 mM, 10 mM, 5 mM, 1 mM, 500 μM, 100 μM, 50 μM, 10 μM, 5 μM, 1 μM, 500 nM, 100 nM, 50 nM, 10 nM, 5 nM, 1 nM, 500 pM, 100 pM, 50 pM, 10 pM, 5 pM, 1 pM, 500 fM, 100 fM, 50 fM, 10 fM, 5 fM, 1 fM, 0.5 fM (first right column). The image was obtained by array reader after slide was washed with PBST (0.05 Tween 20). (c) The curves were obtained by the function of logarithm of printing conc. and median fluorescence intensities. Wash 1 and wash 2 are two independent experiments. (d) Replotted the function of the printing conc. (from 100 mM to 0.05 mM) and median fluorescence intensities. Goodness to fit: R2>0.99 for both lines.
  • FIG. 7 illustrates implementations of sugar chips at different concentrations. Each dark group of four circles represents a protein. The large protein is shown interacting with the light array members. In FIG. 7 a the array members are physically closer together; a protein may therefore interact multivalently as opposed to the situation in FIG. 7 b wherein the physical gap between array members makes it difficult for a protein to interact with multiple array members at the same time.
  • FIG. 8 is a diagrammatic overview of implementations of a sensitive glycan microarray. The sugar fixed to the surface of the substrate interacts with different concentrations of lectin (shown here with a fluorescence attached). To obtain the surface KD value different concentration of inhibitors (light grey connected hexagons) were added, each concentration of inhibitor will generate an isotherm (right bottom chart). Based on the isotherms, the solution KD or Ki for the inhibitors may be obtained.
  • FIG. 9 shows a table providing data on the functions of different printing concentration, and the corresponding fluorescence intensities, and the dissociate constants on surface.
  • FIG. 10 shows a table providing data on competitors and solution Ki values for the interaction with Con A.
  • FIG. 11 shows implementations of quantitative analysis of protein-carbohydrate interactions to obtain surface and solution dissociation constants from glycan arrays. Carbohydrates with reactive groups are immobilized on the array surface. The device (one chip) contains 2 to 50 subarray (*), each subarray contains several carbohydrates. When the device are immobilized with one protein (carbohydrate binding protein) with several (at least 3) concentrations, it will generate an isotherm where the apparent dissociation constant (KD, surf) can be obtained (left isotherm). In the same system, when a different concentrations of carbohydrate (sugar) is co-immobilized with protein. a new isotherm (right isotherm) derived from carbohydrate concentrations and apparent dissociation constants will give the solution dissociation (Ki or KD) of free carbohydrate.
  • DETAILED DESCRIPTION
  • In some exemplary implementations of the disclosure surface-based carbohydrate arrays is used to identify lectin recognition.
  • In some exemplary implementations of the disclosure the presentation of carbohydrates in a microarray provide a system and method to monitor multiple binding events and/or the effects of multivalency. In some instances implementations of the disclosure carbohydrate-proetein interactions on cell surface and in solution can be quantitatively measured by glycan microarray.
  • In some exemplary implementations of the disclosure a glycan microarray with attomol-limits of detection (1 attomol is 10−18 mol of a molecule) is diclosed. Thus, about one milligram of a carbohydrate may be used for a large number of tests. In some instances a milligram of carbohydrate may be used as many as 1012 times. In some instances very slight amounts of antibodies in a subject's blood stream, which can not be detected, by any other known method may be detected.
  • In some exemplary implementations a method for the determination of sugar density using fluorescein isothiocyanate cadaverine to discover, confirm and/or solve the distance of two binding sites within one protein.
  • In some exemplary implementations a method to mimic cell surface carbohydrate-protein interactions of at least one of binding mode and strength of carbohydrate-protein interaction.
  • In some exemplary implementations a glycans array to mimic cell surface carbohydrate-protein interactions of at least one of binding mode and strength of carbohydrate-protein interaction which uses a very small amount of carbohydrate.
  • In some exemplary implementations a method is disclosed to characterize sugar binding specificities of proteins.
  • In some exemplary implementations a method is disclosed for high thorughput identification of inhibitors of carbohydrate-binding proteins.
  • In some exemplary methods disclosed herein the apparent binding mode and strength of carbohydrate-protein interaction on cell surfaces are disclosed to be mimicked and can be quantitatively analyzed by glycan array in a rapid manner using only a very small amount of carbohydrate.
  • According to another aspect, one or more kits of parts can be envisioned by the person skilled in the art, the kits of parts to perform at least one of the methods herein disclosed, the kit of parts comprising one or more microarray devices, a solid substrate configured to provide a supporting substance; and a reactive layer fabricated on the solid substrate, the reactive layer compirising at least one reactive group of small molecules, according to implementations disclosed herein. The kits possibly include devices for reading, operating, interpreting, or processing data produced by the one or more microarrays, as well as instructions for use of the kit and its consituent parts. For example, a kit may include a microarray reader for analyzing a microarray after a reaction.
  • Arraying and detection limit. A strategy for covalently attaching a defined glycan to a glass slide was based on the standard microarray robotic printing technology using N-hydroxysuccinimide (NHS) activated glass surface, to which glycans containing an amine linked to the anomeric position were covalently attached. Prior to producing the slides, the challenges of printing concentrations were examined. Because carbohydrates do not fluoresce and modified carbohydrates bearing fluorescent groups might interact differently with the protein, fluorescein isothiocyanate (FITC) cadaverine was used as a model.
  • FITC cadaverine was printed in concentrations ranging from 100 mM to 1 fM and the slide was scanned before and after washing. The surface coverage of FITC was measured in a fluorescence wash-off experiment and the density of maximum loading was found to be 1014 molecules/cm2 a similar value to most peptides or sugars attached to SPR biosensor surface. More importantly, at concentrations below 100 μM, the fraction of surface covered by each molecule varied in proportion to its concentration, while over 500 μM, the surface seemed to be saturated (FIGS. 6 a-6 d). Next, mono-mannose derivative bearing primary amine (Man1) were printed on the glass slide in concentrations ranging from 100 mM to 0.5 fM (FIG. 1) and incubated with FITC-labeled Con A (100 nM). The limit of detection was found to be in the nanomolar printing concentration, when the ratio of signal to noise was more than 10. This result demonstrates that microarrays require only a very small quantity of carbohydrate; the loading of spot is 0.6 nL and therefore the minimum amount for the detection is attomol (10−18 mole) per spot, allowing several experiments to be carried out on a single glass slide. Assay miniaturization through the construction of high density microarrays is thus well suited for the investigation of carbohydrate-protein interaction.
  • Multivalent Carbohydrate-Protein Interaction on Surface. FITC labeled Con A was incubated with different printing concentrations of Man1 on the surface, after washing the slide was scanned to get the fluorescence intensities. A binding curve based on printing concentrations and fluorescence intensities was created, and the binding curve reached saturation (in the case of FITC-Con A and Man1, the curve became saturated at 10 μM printing conc.), which was independent of surface density (surface saturated when printing concentration was over 100 μM). This saturated curve is an indication of multivalent interaction between protein and printed carbohydrates. As the signal intensity in an array depends on the surfrace density of the immobilized carbohydrate, it is essential to normalize carbohydrate concentrations prior to printing.
  • In order to determine the dissociation constant on surface, protein concentrations were plotted against fluorescence intensity at different concentrations of printed sugar. FIG. 2 a depicts photgraphs of glass slides printed at 16 different concentrations with 16×16 pattern of Man1 from 100 μM (first left column) to 0.1 μM (first right column). The arrays were probed with ten concentrationsof protein-FITC labeled Con A, ranging from 800 nM to 25 nM. Con A concentrations were plotted against median fluorescence intensities of replicate spots to give a set of curves (FIG. 2 b). The curves were analyzed as Langmuir isotherms, assuming that the sytem reached equilibrium during incubation,
  • F = F max [ P ] [ P ] + K D , surf ( 1 )
  • where Fmax is the maximum flourescence intensity, a measure of the amount of active carbohydrate on the surface; [P] is the total lectin concentration; and KD, surf the equilibrium dissociation constant for surface carbohydrate and lectin. Although the printed concentrations of mono-mannose vary by up to 10-fold from 100 to 10 μM, the KD, surf values obtained from these individual curves, as well as from replicate experiments, are narrowly distributed (mean KD, surface=83 nM; s.d.=4.7 nM; FIG. 9). However, at lower printing concentration (ca. 1 μM), the surface reaches a critical density, at which point the binding affinity is lower, probably due to the increased spatial separation (distance) between the carbohydrates on the surface. This is because Con A is capable of forming two attachment points to the surface and the distance between these points is approximately 65 Å. At the printing concentration of over 10 μM, the distance between mannose residues on the surface is close enough such that on average, an adsorbed Con A can bind to two mannose residues. However, when the printing concentration is below 10 mM, the average distance (spatial separation) between immobilized mannose residues is too far for a multivalent interaction with Con A.
  • FIG. 7 provides a diagrammatic overview of the impact of concentration on multivalent binding. Each black group of four circles represent a protein. The protein is respresentative of Con A which has 4 binding sites (each site is separated by a distance of about 6.5 nm). The light grey dots attached to the substrate are representative of sugar on the surface. When printing of the sugars is at low concentration the distance between any 2 sugars is represented in FIG. 7 a. In FIG. 7 a the distance between 2 binding sites is too far for the protein with multiple binding sites to interact with more than one sugar. FIG. 7 b represents the sugars printed at a higher concentration, in this case sugars have spatial separation which is close enough for the protein to interact with 2 sugars. (The KD, surf values indicated that for a printing con ≦1 μM, the KD, surf value increased and there was less tight binding), at this low concentration the average distance between 2 sugars (glycans) is about 10 nm.
  • The increase in binding strength for multivalent interactions is shown in the KD, surf values for high surface densities of a carbohydrate is the result of multivalent interactions. It is well known that carbohydrate-binding proteins interact weakly with monovalent ligands but strongly with multivalent carbohydrates. FITC washing-off experiment indicated that the average space between each sugar is about 100 Å at printing concentration of 1 μM. This result verifies FITC to be an appropriate model for the determination of sugar density1. Accordingly, in some exemplary implementations a method is disclosed to determine the distance of two binding sites within one protein. Applying at least some aspects of this method, different carbohydrates (Man1, Man4, Man8, Man9—see FIG. 3 a) were printed at 100 μM and measured their binding to different proteins at different concentrations. The mannose binding lectings Con A, Lens culinaris agglutinin (LCA), Pisum sativum agglutinin (PSA), and the human monoclonal antibody-2G12 were each incubated with sugar arrays in different concentrations.
  • The model dislcosed herein for binding fit the data well and KD, surf values were obtained using eq 1 (FIG. 3 b). The relative binding affinities of these lectins to surface mannose were observed as Con A>LCA>PSA. The binding affinities of Con A to the four carbohydrates were however close, all about 80 nM and consistent with the values determined by SPR. The relative binding specificity of LCA was Man9≈Man8≈Man4>Man1 and this strongly supported that LCA preferentially binds to poly-mannose structure. The garden pea lectin PSA is thought to have the same binding specificity to LCA, but in this experiment it was found that the binding trend of PSA to these oligosaccharides was similar to Con A, albeit weaker (up to two orders of magnitude). The human monoclonal antibody 2G12 against the mannose epitope of gp120 on HIV was reported to be in favor of the Mana1-2 Man structure. From this study, Man1 has no interaction and Man4 displayed the strongest interaction with KD of 140 nM. These values were consistent with previous measurements from the microtiter plate assay.
  • We also compared the binding strength of lectins or antibodies to mannose derivatives at one or two concentrations of these proteins and obtained a ranking order for binding specificities. For example, the relative binding strength, based on maximal fluorescence intensitites, is Man4 (Fmax=36070)>Man9 (Fmax=25780)>Man8 (Fmax=13940)>Man1 (Fmax=9458), but that based on dissociation constants is Man8 (KD=320 nM)>Man9 (KD=335 nM)>Man4 (KD=490 nM)>Man1 (KD=3190 nM). Prior studies of carbohydrate-protein interactions have used a threshold-based, one-step qualitative analysis i.e. interaction or non-interaction. The threshold varies from one carbohydrate to another and is based on how well the carbohydrate behaves in the assay. Even when closely related glycans are studied under ideal conditions, they vary with respect to the surface density of active carbohydrates. Since the intensity of a spot depends both on KD, surf (which results from binding affinity), and Fmax (which results from surface active carbohydrate density and protein binding), the information obtained by probing an array with a single concentration of analytes may not be accurate. This present disclosures show that quantitative measurements can be carried out to accurately study the nature of carbohydrate-protein interaction on a cell surface.
  • Solution Dissociation Constant. The solution equilibrium dissociation constant (KD) for carbohydrate-lectin interactions can be determined using microarrays in a competitive assay. The analysis allows for the direct comparison between microarry affinities measurements to those obtained from solution-based affinity measurements. In a competitive binding experiment, carbohydrates in solution compete with immobilized carbohydrate ligands for the binding sites on the lectin, establishing a coupled equilibrium between the binding of proetin to the immobilized species and to the species present in the solution. Using array imaging signals, the unbound protein concentration [P] can be obtained via Langmuir isotherms (eq 1). Once the concentration of P has been measured, it is possible to determine the KD using eq 2, which is derived from the multivalent Scatchard formula (see the Experimental Section for the derivation of eq 2)
  • F = F max [ Po ] [ Po ] + K D , surf ( 1 + [ Lo ] K D ) ( 2 )
  • where [Lo] is ligand (carbohydrate) concentration applied to the system, and KD is the solution equilibrium dissociation constant. The derivation of this equation makes four assumptions: (1) the non-specific binding of protein to the slide surface is negligible compared to the total amount of protein in the system; (2) the binding sites in the protein bind to the ligand independently; (3) the initial concentration of ligand is much greater than the initial concentration of protein so that the concentration of unbound ligand is approximately equal to the total concentration of ligand (i.e., [Lo]≈[L]); and (4) the initial protein concentration for the system is greater than the initial concentration of protein-ligand complex (i.e., [Po]≈[P]). A competition binding experiment was performed by treating Con A to various oligomannoses, followed by incubation with corresponding oligomannoses surface. Binding curves, representing different concentrations of competitors were obtained as the function of FITC-Con A concentrations and fluorescence intensities from the Man8 surface (FIG. 4 a). The data was analyzed according to eq 2, to afford apparent KD values, which were then replotted against competitor concentration to afford the solution KD values (FIG. 4 b). Using this analysis, the KD values for Man1, Man4, Man8, Man9 for Con A were found to be 250 μM, 55 μM, 0.42 μM, and 0.13 μM, respectively. These values agree well with the solution dissociation constants of 0.3˜1.0 mM for either Man8 or Man 9 derivatives obtained from SPR followed by HPLC analysis. This analysis clearly shows that Man9 is more than 103 fold stronger than Man1 in binding to Con A. This is because Man8 and Man9 are bivalent ligands containing the α(1,6) and α(1,3) arms of the core residue; where the α(1,6) was identified as the high affinity or primary site and α(1,3) arm as the low affinity or secondary site. A comparison of the solution KD (ex. 250 μM for the monovlent Man1) and the KD, surf (83 nM) values provide the extent of multivalent effect.
  • Competitive Inhibitors of carbohydrate-Binding Proteins in Solution. When different inhibitors (such as α-methyl mannose (a-MeMan), α-methyl glucose (a-MeGlc), and etc.) are applied to the system, binding curves can be analyzed using eq 10 and the inhibition constant Ki can be obtained. Different concentrations of inhibitors were incubated with the slide bound with a protein of interest (FIG. 5), the fluorescent intensities were monitored, and then the Ki values were determined (FIG. 10). The values agree well with the K, of 92 μM and 290 mM (for a-MeMan and a-MeGlc, respectively) obtained by SPR, and with the Ki of 120 μM and 520 μM (for a-MeMan and a-MeGlc, respectively) obtained by microcalorimetry measurements. The relative affinity value of a-MeMan to a-MeGlc (KD (a-MeGlc)/KD (a-MeMan)=4.3) is consistent with the result obtained from microcalorimetry measurements and dextran precipitation induced by Con A. These results indicate that this competition assay can reproduce the binding constants determined by well-tested solution methods. In addition, this method has an advantage in that only one surface is needed to rapidly measure a variety of inhibitors. Moreover, the microarray competition assay can illuminate the molecular features important for carbohydrate-protein complexation and will provide a basis for optimizing inhibitor structure.
  • The glycan array system described here offers several features that make it attractive as a tool for glycomics: it requries small quantities of materials (10−18 mole) for high-throughput analysis, and can be used for quantitative analysis of carbohydrate-protein interaction on surface and in solution. The disclosed system is considered to be a good mimic of cell-surface arrays of carbohydrates in which the dissocation constants of multivalent interactionscan be determined for comparison with the monovalent, solution dissociation constants determined through the competition analysis.
  • EXAMPLE 1
  • Materials. NHS-coated glass slides (Nesterion H slide, SCHOTT North America; high density amine binding slide, Amersham bioscience), FITC labeled Concanavalin A (Con A, Sigma), FITC labeled Lens culinaris agglutinin (LCA, Sigma) and FITC labeled Pisum sativum agglutinin (PSA, Sigma), α-methyl mannose (Vecotr laboratory), α-methyl galactose (Sigma). Mannose derivatives (Man1, Man4, Man8, Man9) were synthesized as previously described.
  • EXAMPLE 2
  • Microarray Fabrication. Microarrays were printed (Genomic Solutions, Gene Machine) by robotic pin (SMP2B, TeleChem International Inc.) deposition of ˜0.6 nL of various concentrations of amine-containing glycans in print buffer (300 mM phosphate, pH 8.5 containing 0.005% Tween-20) from a 384 well plate onto slides. The slide for (1) the scope of printing concentration studies: NHS-coated glass slides were printed with Man1 and FITC at 30 concentrations between 0.5 fM to 100 mM from left to right with 16 replicates vertically placed in each sub-array consisted of a 30×16 pattern of spots, with a 0.25 mm pitch. After 1 h reaction, the slides surface was divided by drawing with permanent marker to avoid contamination for later protein incubation; (2) the slide for FIG. 2 was printed with Man1 with concentrations of 100 (first left column), 80, 60, 40, 30, 20, 10, 8, 6, 4, 2, 1, 0.8, 0.6, 0.4, and 0.1 mM (first right column, 16 different conc.) from left to right with 16 replicates vertically placed in each grid and totally 24 replicates (8×3 pattern) sub-arrays in one slide; (3) the slides for KD, surf and KD determination: the slides were printed of Man1, Man4, Man8, Man9 with concentration of 100 μM from right to left 16 replicates vertically placed in each grid and totally 24 sub-arrays replicates in one slide. After 1 day reaction, the slides were washed with PBST buffer (0.05% Tween 20) for 30 min and then blocked with blocking solution (super-block blocking buffer in PBS, Pierce) for another 1 hour. The slides were dried by pruging with Ar gas and then stored at room temperature in a desiccator. The slides were washed with PBS buffer (pH 7.4) before use.
  • EXAMPLE 3
  • Fluorescence wash-off measurements. FITC cadaverine (FIG. 6 a) with concentration from 100 mM to 1 fM were printed onto the slide in 16 replicates and read at A488 by array scanner (Applied Precision). After 12 hr reaction at dark, the slide was washed with PBST (0.05% Tween 20) buffer. The slide was dried, and then read again at A488 by array reader (FIG. 6 b). The average intensity from each concentration was plotted (FIG. 6 c). The curve showed that at concentrations below 100 μM, the fraction of surface covered by each molecule varied in proportion to its concentration (FIG. 6 d). Over 500 μM, the surface seems to be saturated (FIG. 6 c). The number of FITC that remain bound to the surface (Np) is calculated by eq 3.
  • Np = CVN A Qpost Qpre ( 3 )
  • Since the printing concentration, C=500 μM or 100 μM, and the volume, V=0.6 nL, NA is Avogadro's Number. Each spot in the array is around 0.1 mm diameter.
  • When the surface is saturated (around 100 mM to 500 mM printing FITC), the ratio from pre-quench (Qpre) to post-quench (Qpost) is 0.23 (obtained from the array scanner measurement before and after washing). Based on equation 3, the surface density is between 1.8×1014 molecules/cm2 and 8.8×1014 molecules/cm2. When the printing concentration at 1 mM, the ratio of Qpost/Qpre is 0.1, the density is 0.77×1012 molecules/cm2. If the surface was assumed to be of a homogenous distribution, the average space between each molecule is 115×10−8 m (115 Å).
  • EXAMPLE 4
  • Direct Binding Assay. FITC-labeled Con A (4 mg/ml), FITC-labeled PSA (2 mg/ml), FITC-labeled LCA (2 mg/ml), were diluted in PBS-BSA buffer 50 mM, pH 6.5; 1 mM CaCl2, 1 mM MnCl, 0.9% NaCl (w/v), 1% BSA (w/v)). Human monoclonal antibody-2G12 was used in PBST buffer with 1% BSA. For all incubations, 10-25 μL of protein solution was applied to each sub-array using a 24 well bottomless incubation chamber (The Gel Company). Humidifying incubation was performed under foil and using a shaker for 1 h at room temperature. The slide was washed three times with incubation buffer, three times with PBST buffer (0.05% Tween-20), three times with distilled water, and then centrifuged at 200 g for 5 min to ensure complete dryness. The array was then imaged at a resolution of 5 Å mwith a A488 laser using ArrayWorx microarray reader to visualize fluorescence. The method for the interaction of human monoclonal antibody-2G12 with sugars was similar to lectin. 2G12 in PBST buffer with 1% BSA was pre-complex with Cy3 labeled goat anti-human IgG (Jackson ImmunoResearch) and then placed to the slide and incubated for 1 h. The images were read using A595 laser with the array reader.
  • EXAMPLE 5
  • Competitive Binding Assay. 15 μl of series dilutions of competitor was incubated with different concentrations of protein (15 μl). The mixture was then loaded onto the slides by using a 24 well incubation chamber and incubated for 1 h under a humidifying container at room temperature. The following procedure is the same as the direct binding assay.
  • EXAMPLE 6
  • Data analysis. ArrayVision 8.0 (Applied Precision) was used for the fluorescence analysis and extraction of data. Equilibrium binding data were analyzed by fitting the data to the appropriate equation, assuming that ligands bound to one or two independent sites, using the commercial non-linear regression program GrapPad PRISM (GraphPad). The error bars indicated in the figures show the average percentage error for all data points reported in the figures.
  • EXAMPLE 7
  • Calculation. The formation of surface-bound complex (LP) on the slide between analyte protein (P) and surface bound ligand (L) can be generally considered to the simple bimolecular reversible reaction scheme.
  • Figure US20150094237A1-20150402-C00001
  • The observed rate of complex formation may be written
  • [ Lp ] t = K a [ L ] [ P ] - K b [ LP ] ( 4 )
  • The concentration of unoccupied ligand [L] is the difference between the total amount of ligand [Lo] and the amount of [LP]. Substituting [Lo]-[LP] for [L] in eq 4 gives
  • [ Lp ] t = K a [ P ] ( [ Lo ] - [ LP ] ) - K b [ LP ] ( 5 )
  • if the total amount of ligand [Lo] is expressed in terms of maximum analyte binding capcity of the surface, all concentration terms can then be expressed a binding signal response (F).
  • [ F ] t = K a [ P ] ( F max - F ) - K b F ( 6 )
  • When at equilibrium d[F]/dt=0 and KD, surf=kd/ka, the dissociation constant of ligand and protein complex is obtained as shown in eq 1.
  • The interaction between a monovalent ligand (L) in the solution, a monovalent ligand (L) on the surface, and a multivalent protein (P) can be represented as
  • Figure US20150094237A1-20150402-C00002
  • The expression for the equilibrium solution dissociation constant for this interaction is
  • K D = [ L ] [ P ] [ LP * ] ( 7 )
  • where [LP*] is the concentration of protein/ligand complexes, [P] is the concentration of free protein, and [L] is the concentration of free ligand. Since a multivalent protein (P) may have q binding sites (B), the concentration of free binding sites [B] is equal to q[P]. Likewise, the formation of a binding site/ligand complex [BP*] is equal to q[LP*]. From the eq 7, both numberator and denominator muliply q value. The interaction of one acceptor binding site with ligand can be represented as
  • K D = q [ L ] [ P ] q [ LP * ] = [ L ] [ B ] [ LB * ] ( 8 )
  • Since the binding sites in the protein bind to the ligands independently, the individual dissociation constant is therefore the same as protein dissociation constant.
  • Then, a value is defined as ratio of free protein and total protein which is then substituted [LP*] value by eq 7 and rearranged to give eq 9.
  • α = [ P ] [ P ] + [ LP * ] = 1 [ Lo ] K D + 1 ( 9 )
  • To determine KD, the unbound protein in this system is calculated to become a[Po] and which is substituted to eq 1 and rearranges to yield eq 2.
  • The interaction between inhibitors (I) in the solution, a ligand (L) on the surface and multivalent protein (P) can be represented as
  • Figure US20150094237A1-20150402-C00003
  • The array imaging data is used to measure [P] and Ki can be determined by the eq 10.
  • F = F max [ Po ] [ Po ] + K D , surf ( 1 + [ I ] K i ) ( 10 )
  • The fraction of inhibition (f) is equal to 1-F/Fmax, the equation from eq 10 can be rearranged to give eq 11.
  • 1 - F F max = f = [ I ] [ I ] + K i ( 1 + [ Po ] K D ) ( 11 )
  • Shown in FIG. 8 is an exemplar of a method and process of a sugar fixed to the surface of an array substrate interacting with different concentrations of lectin (which a fluorescence attached). To obtain the surface KD value different concentration of inhibitors (shown as light grey connected hexagons) were added to the microarray, each concentration of inhibitor can generate an isotherm (right bottom chart.). Based on the isotherms the solution KD or Ki for the inhibitors may be obtained.
  • While the method and agent have been described in terms of what are presently considered to be the most practical and preferred implementations, it is to be understood that the disclosure need not be limited to the disclosed exemplary implementations. It is intended to cover various modifications and similar arrangements included within the spirit and scope of the claims, the scope of which should be accorded the broadest interpretation so as to encompass all such modifications and similar structures. The present disclosure includes any and all implementations of the following claims.

Claims (10)

What is claimed is:
1. A carbohydrate microarray for protein measurements, comprising:
a solid substrate configured to provide a supporting substance; and
a reactive layer fabricated on the solid substrate, the reactive layer comprising at least one group of small molecules wherein the small molecules comprise at least one of carbohydrates and glycolipids wherein the small molecules are disposed relative to each other to allow the at least one protein to multivalently bond with the small molecules;
wherein the at least one group of small molecules is configured to bind with at least one protein wherein the at least one protein is immobilized on the solid substrate via the reactive layer;
wherein the carbohydrate microarray is configured to perform quantitative measurement of binding with the at least one protein; and
wherein at least one protein of a given concentration is applied whereby the binding affinity between the small molecules and the at least one protein can be measured.
2. The device of claim 1, wherein an average spatial separation between the small molecules ranges from about 65 Angstrom to about 100 Angstrom.
3. The device of claim 1, wherein the proteins comprise at least one of carbohydrate binding proteins and lipid binding proteins.
4. The device of claim 1, wherein the proteins are fluorescence labeled or can be detected by a secondary labeled protein.
5. The device of claim 1, wherein each of the at least one reactive group has at least about 10−18 mole of carbohydrate.
6. The device of claim 1, wherein carbohydrates with reactive groups are immobilized on the surface of the device wherein the arrays comprise about 2 to 50 subarrays wherein each subarray contains one or more carbohydrates.
7. A kit comprising:
a carbohydrate microarray comprising carbohydrate deposited on a solid substrate, each carbohydrate comprising a reactive group of at least one of carbohydrate and glycolipid, wherein the carbohydrates are configured to react with and bind to at least one protein; wherein the reactive groups are disposed relative to each other to allow the at least one protein to multivalently bond with the reactive groups;
a microarray reader; and
instructions for use.
8. The kit of claim 7, wherein the carbohydrates of the microarray are deposited at least about 10−18 mole of carbohydrate molecule per spot.
9. The kit of claim 7, wherein the carbohydrates include at least one glycan.
10. The kit of claim 7, wherein the carbohydrates include at least one glycolipid.
US14/565,323 2008-04-30 2014-12-09 Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants Abandoned US20150094237A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/565,323 US20150094237A1 (en) 2008-04-30 2014-12-09 Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4935808P 2008-04-30 2008-04-30
US12/423,733 US8906832B2 (en) 2008-04-30 2009-04-14 Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants
US14/565,323 US20150094237A1 (en) 2008-04-30 2014-12-09 Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/423,733 Division US8906832B2 (en) 2008-04-30 2009-04-14 Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants

Publications (1)

Publication Number Publication Date
US20150094237A1 true US20150094237A1 (en) 2015-04-02

Family

ID=41257487

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/423,733 Active 2030-12-07 US8906832B2 (en) 2008-04-30 2009-04-14 Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants
US14/565,323 Abandoned US20150094237A1 (en) 2008-04-30 2014-12-09 Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/423,733 Active 2030-12-07 US8906832B2 (en) 2008-04-30 2009-04-14 Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants

Country Status (1)

Country Link
US (2) US8906832B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US10538592B2 (en) 2016-08-22 2020-01-21 Cho Pharma, Inc. Antibodies, binding fragments, and methods of use
US10618973B2 (en) 2014-05-27 2020-04-14 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
US10918714B2 (en) 2013-09-06 2021-02-16 Academia Sinica Human iNKT cell activation using glycolipids with altered glycosyl groups
US11231415B2 (en) 2016-05-12 2022-01-25 Z Biotech Llc Multivalent glycan microarray platform
US11267870B2 (en) 2009-12-02 2022-03-08 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11319567B2 (en) 2014-05-27 2022-05-03 Academia Sinica Fucosidase from bacteroides and methods using the same
US11332523B2 (en) 2014-05-28 2022-05-17 Academia Sinica Anti-TNF-alpha glycoantibodies and uses thereof
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11884739B2 (en) 2014-05-27 2024-01-30 Academia Sinica Anti-CD20 glycoantibodies and uses thereof

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
WO2010009271A2 (en) 2008-07-15 2010-01-21 Academia Sinica Glycan arrays on ptfe-like aluminum coated glass slides and related methods
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
JP6302909B2 (en) 2012-08-18 2018-03-28 アカデミア シニカAcademia Sinica Cell-permeable probes for sialidase identification and imaging
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
CA2937123A1 (en) 2014-01-16 2015-07-23 Academia Sinica Compositions and methods for treatment and detection of cancers
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
CN106415244B (en) 2014-03-27 2020-04-24 中央研究院 Reactive marker compounds and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
CA2960712A1 (en) 2014-09-08 2016-03-17 Academia Sinica Human inkt cell activation using glycolipids
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
CA2972072A1 (en) 2015-01-24 2016-07-28 Academia Sinica Novel glycan conjugates and methods of use thereof
CA3016170A1 (en) 2016-03-08 2017-09-14 Academia Sinica Methods for modular synthesis of n-glycans and arrays thereof
US11884961B2 (en) 2017-06-02 2024-01-30 Georgia State University Research Foundation, Inc. DNA-glycan conjugates and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Lohse et al. (Angew. Chem. Int. Ed. 2006, 45, 4167 -4172) *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11267870B2 (en) 2009-12-02 2022-03-08 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10918714B2 (en) 2013-09-06 2021-02-16 Academia Sinica Human iNKT cell activation using glycolipids with altered glycosyl groups
US10618973B2 (en) 2014-05-27 2020-04-14 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
US11319567B2 (en) 2014-05-27 2022-05-03 Academia Sinica Fucosidase from bacteroides and methods using the same
US11884739B2 (en) 2014-05-27 2024-01-30 Academia Sinica Anti-CD20 glycoantibodies and uses thereof
US11332523B2 (en) 2014-05-28 2022-05-17 Academia Sinica Anti-TNF-alpha glycoantibodies and uses thereof
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US11231415B2 (en) 2016-05-12 2022-01-25 Z Biotech Llc Multivalent glycan microarray platform
US11656224B2 (en) 2016-05-12 2023-05-23 Z Biotech Llc Multivalent glycan microarray platform
US10538592B2 (en) 2016-08-22 2020-01-21 Cho Pharma, Inc. Antibodies, binding fragments, and methods of use

Also Published As

Publication number Publication date
US20090275484A1 (en) 2009-11-05
US8906832B2 (en) 2014-12-09

Similar Documents

Publication Publication Date Title
US8906832B2 (en) Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants
CN100369181C (en) Retentate chromatography and protein chip arrays with applications in biology and medicine
Cretich et al. Protein and peptide arrays: recent trends and new directions
Oh et al. Calixarene derivative as a tool for highly sensitive detection and oriented immobilization of proteins in a microarray format through noncovalent molecular interaction
US6043024A (en) Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
CN100420947C (en) Method for quantitative determination of specific analyte with single trapping agent and reagent kit therefor
US20020021443A1 (en) Apparatus including a biochip for imaging of biological samples and method
JPH03503081A (en) Quantification of environmental concentrations of several test substances
JP3422493B2 (en) Affinity selection of ligands by mass spectroscopy
EP1073903B1 (en) Detection of very low quantities of analyte bound to a solid phase
JPH05504841A (en) Antibodies against ligand receptors and ligand complexes and their use in ligand-receptor assays
JP2004530879A (en) How to build a protein microarray
Pavlickova et al. Microarray of recombinant antibodies using a streptavidin sensor surface self-assembled onto a gold layer
US5620901A (en) Determination of concentration by affinity titration
US20040265923A1 (en) Method and apparatus to determine the performance of protein arrays
EP1512012B1 (en) Biomolecular kinetics method using a flow-through microarray
JP5611831B2 (en) Synthetic immunoreactive peptides with rheumatoid arthritis autoantibodies
US7011955B1 (en) Quantitative determination of analytes in a heterogeneous system
Adak et al. Regioselective SN2-type reaction for the oriented and irreversible immobilization of antibodies to a glass surface assisted by boronate formation
US20020045277A1 (en) Process for detecting biological molecules
US20080058225A1 (en) Artificial receptors, building blocks, and methods
WO2017156038A2 (en) Immunoassay controls and the use thereof
Glycotechnol Unlimited glycochip
WO2003058249A1 (en) Method for quantitation of protein levels in biological samples
Poller et al. Influence of different surface chemistries on the ultrasensitive on-chip detection of enrofloxacin in milk

Legal Events

Date Code Title Description
AS Assignment

Owner name: ACADEMIA SINICA, TAIWAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIANG, PI-HUI;WONG, CHI-HUEY;SIGNING DATES FROM 20141214 TO 20141215;REEL/FRAME:034561/0630

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION